WINT
Income statement / Annual
Last year (2024), Windtree Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Windtree Therapeutics, Inc.'s net income was -$5.49 M.
See Windtree Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$198.00 K |
$1.79 M |
$1.49 M |
$2.04 M |
$987.00 K |
| Cost of Revenue |
$0.00
|
$82.00 K
|
$1.06 M
|
$869.00 K
|
$638.00 K
|
$12.69 K
|
$10.56 M
|
$17.38 M
|
$255.00 K
|
$929.00 K
|
| Gross Profit |
$0.00
|
-$82.00 K
|
-$1.06 M
|
-$869.00 K
|
-$638.00 K
|
$185.31 K
|
-$8.77 M
|
-$15.89 M
|
$1.79 M
|
$58.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0.94
|
-4.91
|
-10.7
|
0.88
|
0.06
|
| Research and Development Expenses |
$16.28 M
|
$8.26 M
|
$11.10 M
|
$17.79 M
|
$15.37 M
|
$12.69 M
|
$10.56 M
|
$17.38 M
|
$31.71 M
|
$28.89 M
|
| General & Administrative Expenses |
$8.74 M
|
$8.70 K
|
$10.79 M
|
$14.47 M
|
$14.94 M
|
$12.40 M
|
$7.42 M
|
$6.66 M
|
$7.17 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$9.19 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.20 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.74 M
|
$9.20 M
|
$10.79 M
|
$14.47 M
|
$14.94 M
|
$12.40 M
|
$7.42 M
|
$6.66 M
|
$8.37 M
|
$11.00 M
|
| Other Expenses |
$1.12 M
|
$3.56 M
|
$702.00 K
|
-$320.00 K
|
-$2.25 M
|
-$446.00 K
|
$401.00 K
|
$129.00 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$26.14 M
|
$20.60 M
|
$21.89 M
|
$32.26 M
|
$30.32 M
|
$25.09 M
|
$17.98 M
|
$24.03 M
|
$40.08 M
|
$39.89 M
|
| Cost And Expenses |
$0.00
|
$17.54 M
|
$21.89 M
|
$32.26 M
|
$30.32 M
|
$25.09 M
|
$17.98 M
|
$24.03 M
|
$40.08 M
|
$40.82 M
|
| Interest Income |
$70.00 K
|
$325.00 K
|
$109.00 K
|
$91.00 K
|
$122.00 K
|
$153.00 K
|
$15.00 K
|
$12.00 K
|
$18.00 K
|
$237.00 K
|
| Interest Expense |
$235.00 K
|
$50.00 K
|
$53.00 K
|
$114.00 K
|
$125.00 K
|
$495.00 K
|
$1.41 M
|
$1.86 M
|
$2.52 M
|
$4.67 M
|
| Depreciation & Amortization |
$0.00
|
$82.00 K
|
$1.06 M
|
$869.00 K
|
$638.00 K
|
$1.11 M
|
$159.00 K
|
$192.00 K
|
$255.00 K
|
$712.00 K
|
| EBITDA |
$0.00 |
-$20.16 M |
-$39.46 M |
-$76.64 M |
-$31.80 M |
-$25.87 M |
-$18.97 M |
-$16.39 M |
-$36.72 M |
-$49.88 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
-130.65
|
-10.61
|
-11.04
|
-17.98
|
-50.53
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
-125.72
|
-9.06
|
-15.18
|
-18.63
|
-40.36
|
| Total Other Income/Expenses Net |
$23.23 M
|
-$2.75 M
|
-$19.09 M
|
-$45.36 M
|
-$2.25 M
|
-$2.58 M
|
-$4.34 M
|
$4.10 M
|
-$1.45 M
|
-$15.34 M
|
| Income Before Tax |
-$1.79 M
|
-$20.29 M
|
-$40.58 M
|
-$77.62 M
|
-$32.57 M
|
-$27.48 M
|
-$20.53 M
|
-$18.45 M
|
-$39.49 M
|
-$55.17 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
-138.76
|
-11.48
|
-12.42
|
-19.34
|
-55.9
|
| Income Tax Expense |
$3.69 M
|
$0.00
|
-$1.37 M
|
-$9.99 M
|
-$2.29 M
|
$2.39 M
|
-$2.93 M
|
$1.99 M
|
$1.20 M
|
$4.67 M
|
| Net Income |
-$5.49 M
|
-$20.29 M
|
-$39.21 M
|
-$67.64 M
|
-$30.28 M
|
-$29.86 M
|
-$20.53 M
|
-$18.45 M
|
-$39.49 M
|
-$55.17 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
-150.82
|
-11.48
|
-12.42
|
-19.34
|
-55.9
|
| EPS |
-104.35 |
-4711.54 |
-56011 |
-122924 |
-93616 |
-113138 |
-1044304 |
-3258910 |
-12798000 |
-21380814 |
| EPS Diluted |
-104.35 |
-4711.54 |
-56011 |
-122924 |
-93616 |
-113138 |
-1044304 |
-3258910 |
-12815253 |
-21380814 |
| Weighted Average Shares Out |
$52.58 K
|
$4.31 K
|
$700.00
|
$550.22
|
$347.87
|
$242.84
|
$33.28
|
$7.61
|
$3.08
|
$2.58
|
| Weighted Average Shares Out Diluted |
$52.58 K
|
$4.31 K
|
$700.00
|
$550.22
|
$347.87
|
$242.84
|
$33.28
|
$7.61
|
$3.08
|
$2.58
|
| Link |
|
|
|
|
|
|
|
|
|
|
